Healthcare Purchasing News
  • Magazine
  • Continuing Education
  • Webinars
  • Whitepapers
  • Videos
  • Events
  • Hall of Fame
  • Advertise
  • Source Guide
  • Subscribe
  • Sourcing & Logistics
  • Sterile Processing
  • Surgical & Critical Care
  • Patient Satisfaction
  • Infection Prevention
  • EVS & Facility Services
  • Healthcare IT
  • Regulatory
  • Topics
    Sourcing & LogisticsSterile ProcessingSurgical & Critical CarePatient SatisfactionInfection PreventionEVS & Facility ServicesHealthcare ITRegulatory
    Resources
    HPN Source GuideContinuing EducationWebinarsWhitepapersVideosEventsHall of FameAdvertiseAd Specs
    User Tools
    SubscribeContact UsAbout UseNewsletterMagazinesPrivacy PolicyTerms & Conditions
    https://www.facebook.com/hpnonline
    https://www.linkedin.com/company/healthcare-purchasing-news/
    https://twitter.com/HPN_Online
    1. Regulatory

    B. Braun Medical Inc. recalls 0.9% Sodium Chloride

    March 7, 2022
    Courtesy of the FDA
    Courtesy of the FDA
    Courtesy of the FDA

    As reported by the U.S. Food and Drug Administration (FDA), B. Braun Medical Inc. (B. Braun) is voluntarily recalling five (5) lots of 0.9% Sodium Chloride for Injection USP 250ML in Excel within the United States to the hospital/user level. The voluntary recall has been initiated due to fluid leakage or low fill volume of the respective containers.

    The biggest risk with a slow leak in any intravenous solution preparation is a break in sterility which poses a risk for the patient being exposed to a bacterial or fungal infection. There is a remote probability this could lead to bloodstream infection. B. Braun has not received any reports of adverse events related to this recall.

    0.9% Sodium Chloride for Injection USP in Excel is indicated for extracellular fluid replacement, treatment of metabolic alkalosis in the presence of fluid loss and mild sodium depletion. 0.9% Sodium Chloride Injection USP in Excel is also indicated for use as a priming solution in hemodialysis procedures and may be used to initiate and terminate blood transfusions without hemolyzing red blood cells.

    The product was distributed Nationwide within the United States to domestic distributors.

    FDA News Release

    Latest in Regulatory

    Photo 283661651 © Michał Rojek | Dreamstime.com
    Regulatory

    FDA issues final guidance: Assessing the Credibility of Computational Modeling and Simulation in Medical Device Submissions

    Nov. 21, 2023
    Photo 246006971 © Andrei ASKIRKA | Dreamstime.com
    Regulatory

    New social determinants of health resources released

    Nov. 20, 2023
    Photo 226446952 © Ralf Liebhold | Dreamstime.com
    Regulatory

    HHS establishes Secretary’s Advisory Committee on Long COVID

    Nov. 20, 2023
    Photo 65457393 © Goodluz | Dreamstime.com
    Regulatory

    FDA issues warning letter to Amazon

    Nov. 16, 2023
    Photo 125652381 © Ig0rzh | Dreamstime.com
    Regulatory

    National Climate Assessment 5 unveiled

    Nov. 14, 2023
    Healthcare Purchasing News
    https://www.facebook.com/hpnonline
    https://www.linkedin.com/company/healthcare-purchasing-news/
    https://twitter.com/HPN_Online
    • About Us
    • Contact Us
    • Advertise
    • Do Not Sell or Share
    • Privacy Policy
    • Terms & Conditions
    © 2023 Endeavor Business Media, LLC. All rights reserved.
    Endeavor Business Media Logo